Bradykinin
Bradykinin is a peptide that causes blood vessels to dilate (enlarge), and therefore causes blood pressure to fall. It is a part of the kallikrein-kinin system, which is a complex system of blood proteins that play a role in inflammation, blood pressure control, coagulation, and pain.
Structure and Function[edit | edit source]
Bradykinin is a nonapeptide, meaning it is composed of nine amino acids. The sequence of these amino acids is Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg. Bradykinin is produced from a precursor protein called kininogen through the action of the enzyme kallikrein.
Physiological Role[edit | edit source]
Bradykinin is involved in several physiological processes:
- **Vasodilation**: It causes the dilation of blood vessels, which leads to a decrease in blood pressure.
- **Pain**: Bradykinin is known to induce pain by stimulating sensory neurons.
- **Inflammation**: It plays a significant role in the inflammatory response by increasing the permeability of blood vessels, allowing immune cells to reach the site of infection or injury.
- **Smooth Muscle Contraction**: It can cause the contraction of smooth muscle in the bronchi and gastrointestinal tract.
Pathophysiology[edit | edit source]
Bradykinin is implicated in several pathological conditions:
- **Hereditary Angioedema**: A genetic disorder characterized by recurrent episodes of severe swelling. This condition is often due to a deficiency in C1 inhibitor, which normally regulates the production of bradykinin.
- **Septic Shock**: Excessive production of bradykinin can contribute to the severe drop in blood pressure seen in septic shock.
- **Chronic Pain**: Elevated levels of bradykinin are associated with chronic pain conditions.
Clinical Significance[edit | edit source]
Bradykinin levels can be influenced by certain medications:
- **ACE Inhibitors**: These drugs, used to treat high blood pressure, can increase bradykinin levels by inhibiting its breakdown, which can sometimes lead to a side effect known as ACE inhibitor-induced angioedema.
- **Kininase Inhibitors**: These are experimental drugs that aim to modulate the effects of bradykinin for therapeutic purposes.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD